| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.55 mm | 4.55 mm | 4.55 mm | 4.55 mm | 4.55 mm | 4.55 mm |
| Cash burn (monthly) | 901.84 k | (no burn) | 811.39 k | 915.43 k | (no burn) | 243.11 k |
| Cash used (since last report) | 1.89 mm | n/a | 1.70 mm | 1.92 mm | n/a | 510.15 k |
| Cash remaining | 2.66 mm | n/a | 2.85 mm | 2.63 mm | n/a | 4.04 mm |
| Runway (months of cash) | 3.0 | n/a | 3.5 | 2.9 | n/a | 16.6 |
| 13F holders | Current |
|---|---|
| Total holders | 11 |
| Opened positions | 9 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 64.42 mm |
| Total shares | 2.86 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Alpha 18 | 1.50 mm | $341.00 k |
| L1 Capital Global Opportunities Master Fund | 776.38 k | $908.00 k |
| CVI Investments | 400.53 k | $204.00 k |
| Warberg Asset Management | 48.80 k | $26.50 mm |
| Bayer Healthcare | 48.32 k | $25.00 k |
| Two Sigma Securities | 34.16 k | $18.55 mm |
| Geode Capital Management | 27.10 k | $14.72 mm |
| Virtu Financial | 21.31 k | $12.00 k |
| NA.R National Bank of Canada | 5.00 k | $2.72 mm |
| Tower Research Capital | 799.00 | $434.00 k |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Mar 24 | Norm Staskey | Common Stock | Buy | Acquire P | No | No | 0.2108 | 47,600 | 10.03 k | 51,100 |
| 13 Feb 24 | Norm Staskey | Common Stock | Buy | Acquire P | No | No | 0.3 | 3,300 | 990.00 | 3,500 |
| 13 Feb 24 | Travis Whitfill | Common Stock | Buy | Acquire P | No | No | 0.3 | 15,000 | 4.50 k | 334,500 |
| 13 Feb 24 | Francisco D. Salva | Common Stock | Buy | Acquire P | No | No | 0.3 | 333,300 | 99.99 k | 338,300 |
| 8 Sep 23 | Norm Staskey | Stock Options Common Stock | Grant | Acquire A | No | No | 2.07 | 10,000 | 20.70 k | 10,000 |
